Senate moves to limit access to Chinese contract manufacturing, development

Congress is escalating efforts to decouple the U.S. and Chinese life sciences industries.  

Thursday evening, the Senate voted to attach a revised version of the Biosecure Act to the National Defense Authorization Act (NDAA), while the House of Representatives last month amended its version of the legislation with a bill that would end most U.S.–China academic research collaborations. ...